These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 8940710

  • 21. Diagnostic value of 99mTc MIBI scintimammography in patients with breast lesions.
    Yildiz A, Colak T, Güngör F, Ozuğur S, Boz A, Tunçdemir F, Akaydin M.
    Rev Esp Med Nucl; 2001 Jun; 20(4):276-81. PubMed ID: 11440709
    [Abstract] [Full Text] [Related]

  • 22. Technetium-99m-tetrofosmin in diagnosis of breast cancer and axillary lymph node involvement.
    Jaukovic LDj, Ajdinovic BZ, Jankovic ZD, Strbac M.
    Nucl Med Rev Cent East Eur; 2006 Jun; 9(1):30-6. PubMed ID: 16791801
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Can scintimammography with (99m)Tc-MIBI identify multifocal and multicentric primary breast cancer?
    Cwikla JB, Buscombe JR, Holloway B, Parbhoo SP, Davidson T, McDermott N, Hilson AJ.
    Nucl Med Commun; 2001 Dec; 22(12):1287-93. PubMed ID: 11711898
    [Abstract] [Full Text] [Related]

  • 25. Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and technetium-99m methoxyisobutylisonitrile scintimammography in the detection of breast tumours.
    Palmedo H, Bender H, Grünwald F, Mallmann P, Zamora P, Krebs D, Biersack HJ.
    Eur J Nucl Med; 1997 Sep; 24(9):1138-45. PubMed ID: 9283107
    [Abstract] [Full Text] [Related]

  • 26. (99)mTc-tetrofosmin SPET in the detection of both primary breast cancer and axillary lymph node metastasis.
    Spanu A, Dettori G, Nuvoli S, Porcu A, Falchi A, Cottu P, Solinas ME, Scanu AM, Chessa F, Madeddu G.
    Eur J Nucl Med; 2001 Dec; 28(12):1781-94. PubMed ID: 11734916
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [A Spanish multicenter scintigraphic study of the breast using Tc 99m MIBI. Report of results].
    Prats E, Carril J, Herranz R, Meroño E, Banzo J, Gtemegmmt YE.
    Rev Esp Med Nucl; 1998 Dec; 17(5):338-50. PubMed ID: 9812008
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Technetium-99m methylene diphosphonate scintimammography for evaluation of palpable breast masses.
    Lee JK, Kao CH, Sun SS.
    Oncol Rep; 1999 Dec; 6(3):659-63. PubMed ID: 10203611
    [Abstract] [Full Text] [Related]

  • 32. 99Tcm-sestamibi scintimammography in patients with suspicious breast lesions: comparison of SPET and planar images in the detection of primary tumours and axillary lymph node involvement.
    Schillaci O, Scopinaro F, Danieli R, Tavolaro R, Picardi V, Cannas P, Colella AC.
    Nucl Med Commun; 1997 Sep; 18(9):839-45. PubMed ID: 9352550
    [Abstract] [Full Text] [Related]

  • 33. Comparative evaluation of 99mTc-MIBI and 99mTc-HMDP scintimammography for the diagnosis of breast cancer and its axillary metastases.
    Nishiyama Y, Yamamoto Y, Ono Y, Irie A, Yamauchi A, Satoh K, Ohkawa M.
    Eur J Nucl Med; 2001 Apr; 28(4):522-8. PubMed ID: 11357504
    [Abstract] [Full Text] [Related]

  • 34. Chest wall recurrence of breast cancer demonstrated on 99mTc-MIBI scintimammography.
    Usmani S, Niaz K, Maseeh-Uz-Zaman, Niyaz K, Khan HA, Habib S, Kamal S.
    Nucl Med Commun; 2007 Nov; 28(11):842-6. PubMed ID: 17901766
    [Abstract] [Full Text] [Related]

  • 35. Tc-99m MIBI in suspected recurrent breast cancer.
    Cwikla JB, Kolasinska A, Buscombe JR, Hilson AJ.
    Cancer Biother Radiopharm; 2000 Aug; 15(4):367-72. PubMed ID: 11041021
    [Abstract] [Full Text] [Related]

  • 36. Incremental diagnostic value of quantitative analysis of double phase Tc-99m MIBI scintimammography for the detection of primary breast cancer additive to visual analysis.
    Kim SJ, Kim IJ, Bae YT, Kim YK, Kim DS.
    Breast Cancer Res Treat; 2004 Jan; 83(2):129-38. PubMed ID: 14997043
    [Abstract] [Full Text] [Related]

  • 37. Mammography and 99mTc-MIBI scintimammography in suspected breast cancer.
    Prats E, Aisa F, Abós MD, Villavieja L, García-López F, Asenjo MJ, Razola P, Banzo J.
    J Nucl Med; 1999 Feb; 40(2):296-301. PubMed ID: 10025838
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Role of 99mTc-MIBI scintimammography and X-ray mammography in the diagnosis of locoregional recurrence of breast cancer.
    Usmani S, Niaz K, Maseeh-Uz-Zaman, Kamal S, Niyaz K, Mehboob J, Hashmi A, Habib S, Hashmi H.
    J Pak Med Assoc; 2007 Apr; 57(4):172-5. PubMed ID: 17489522
    [Abstract] [Full Text] [Related]

  • 40. Contribution of 99mTc-anti-carcinoembryonic antigen antibody and 99mTc-sestamibi scintimammography in the evaluation of high risk palpable breast lesions.
    Sanidas EE, Koukouraki S, Velidaki A, Manios A, Stathopoulos E, De Bree E, Kafousi M, Kodogiannis E, Karkavitsas N, Tsiftsis DD.
    Nucl Med Commun; 2003 Mar; 24(3):291-6. PubMed ID: 12612470
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.